Effectiveness of modified Buzhong Yiqi decoction in treating myasthenia gravis: study protocol for a series of N-of-1 trials

BACKGROUND: Myasthenia gravis (MG) is an acquired autoimmune disease with high heterogeneity. The disease is chronic, relapsing repeatedly and progressive with acute exacerbation occasionally. Although the treatment of MG has developed, it is still unsatisfactory and has some unexpected side effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Senhui, Li, Jinghao, Chen, Benshu, He, Long, Zhong, Zhuotai, Huang, Linwen, Zhang, Shijing, Liu, Fengbin, Jiang, Qilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044679/
https://www.ncbi.nlm.nih.gov/pubmed/35477531
http://dx.doi.org/10.1186/s13063-022-06287-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044679/
https://www.ncbi.nlm.nih.gov/pubmed/35477531
http://dx.doi.org/10.1186/s13063-022-06287-9

Ejemplares similares